Fidelity Investments’s SYNAGEVA BIOPHARMA CORP COM STK (DE) GEVA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2015
Q2 | – | Sell |
-5,543,741
| Closed | -$541M | – | 2882 |
|
|
2015
Q1 | $541M | Buy |
5,543,741
+959,650
| +21% | +$93.6M | 0.07% | 323 |
|
|
2014
Q4 | $425M | Buy |
4,584,091
+701,050
| +18% | +$65.1M | 0.06% | 382 |
|
|
2014
Q3 | $267M | Buy |
3,883,041
+272,440
| +8% | +$18.7M | 0.04% | 522 |
|
|
2014
Q2 | $378M | Buy |
3,610,601
+923,637
| +34% | +$96.8M | 0.05% | 411 |
|
|
2014
Q1 | $223M | Sell |
2,686,964
-350,255
| -12% | -$29.1M | 0.03% | 605 |
|
|
2013
Q4 | $197M | Sell |
3,037,219
-147,409
| -5% | -$9.54M | 0.03% | 640 |
|
|
2013
Q3 | $202M | Buy |
3,184,628
+378,541
| +13% | +$24M | 0.03% | 605 |
|
|
2013
Q2 | $118M | Buy |
+2,806,087
| New | +$118M | 0.02% | 837 |
|